Gwenn M. Hansen
Chief Scientific Officer Nurix Therapeutics, Inc.
Seminars
            Tuesday 28th October 2025
        
        Clinical Update on Bexobrutideg: The First “-Deg”
    
    
        
            12:15 pm
            
        
    
    
					Chief Scientific Officer Nurix Therapeutics, Inc.